Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Anthera Pharmaceuticals Inc    

ANTHERA PHARMACEUTICALS INC

 SummaryNewsCalendarCompany 
Company
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates,... 
More about the company
Latest news on ANTHERA PHARMACEUTICALS IN
2018ANTHERA PHARMACEUTICALS : Announces SEC Deregistration
PU
2017ANTHERA PHARMACEUTICALS INC : REVERSE SPLIT: 1 of 8
FA
2017Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
GL
2017Anthera Announces Completion of Dosing in the Phase 2 BRIGHT-SC Study of Blis..
GL
2017DEADLINE ALERT : Brower Piven Reminds Investors Of The Upcoming Deadline In Clas..
BU
2017Anthera Announces Positive Results from the Extension Period of the SOLUTION ..
GL
2017ANTH The Law Offices of Vincent Wong Reminds Investors of a Class Action Invo..
BU
2017Anthera Pharmaceuticals Announces Pricing of $15.0 Million Public Offering of..
GL
2017Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock an..
GL
2017Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 Fr..
BU
More news
Analyst Recommendations on ANTHERA PHARMACEUTICALS IN
More recommendations
Sector news : Bio Therapeutic Drugs
08/22GSK's long acting HIV injection gets boost from study
RE
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/12REGENERON PHARMACEUTICALS : Two Experimental Ebola Drugs Reduce Mortality Rate
DJ
08/08Sarepta says adverse event report for DMD gene therapy erroneously submitted
RE
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
More sector news : Bio Therapeutic Drugs
Chart ANTHERA PHARMACEUTICALS INC
Duration : Period :
Anthera Pharmaceuticals Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANTHERA PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Managers
NameTitle
John Craig Thompson President, CEO & Executive Director
Paul F. Truex Executive Chairman
May Liu CAO, Senior VP-Finance & Administration
David E. Thompson Independent Director
Christopher S. Henney Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHERA PHARMACEUTICALS INC1
GILEAD SCIENCES2.67%81 218
VERTEX PHARMACEUTICALS11.18%47 911
REGENERON PHARMACEUTICALS-21.01%32 584
GENMAB28.01%13 309
NEUROCRINE BIOSCIENCES, INC.36.17%9 007